Alzheimer's Disease News

What's on the Horizon for Alzheimer's Disease and IVIG News?

Here you can find the latest IVIG news, including Alzheimer's disease news, home infusion news and more. Read the articles below to find out what's on the horizon for IVIG news within American Outcomes Management (AOM) and beyond.

Alzheimer's Disease News: Recent Studies Show Positive Results Using IVIG in the Treatment of Alzheimer's Disease.

The medical and scientific community continues to search for important answers to combat and ultimately prevent Alzheimer's disease. Research efforts have identified the beta amyloid protein as the component of the amyloid plaques that accumulate in the brains of people with Alzheimer's disease.

Beta-amyloid is viewed by many researchers and clinicians as the underlying cause of the degeneration and dementia that characterize the illness. It has been discovered that IVIG, which is derived from human blood, contains antibodies that bind to the beta amyloid protein. Results from a recently presented clinical study show that IVIG appears to promote the clearance of beta amyloid from the brain and block its toxic effects on brain cells resulting in a stabilization or improvement in the global outcomes and activities of daily living of patients with Alzheimer's disease.

Although IVIG is not currently approved to treat Alzheimer's disease, in the fall of 2008, 35 academic institutions in conjunction with the NIH and the Alzheimer's Disease Cooperative Study Group will engage in a Phase III clinical trial to try and confirm the encouraging results using IVIG that have been reported in the Phase I and Phase II trials. In the earlier trials it was shown that patients tolerated the IVIG therapy with minimal adverse reactions and all patients had stabilization of their cognitive abilities with many of them demonstrating a significant improvement in cognitive ability over the course of the six months of IVIG treatment.

Learn more about the double-blind Phase II alzheimer's disease clinical trial reported from Weill Medical College of Cornell University using IVIG therapy in the treatment of Alzheimer's disease.

Visit our Alzheimer's disease blog.

For more information on AOM's home infusion services, please visit our Home Infusion FAQs or contact us at 1-800-746-9089. Press zero to speak to an AOM staff member 9am-5pm, Monday through Friday. We will be happy to answer all of your questions about AOM and our home infusion therapy.

If you are a physician and would like to refer a patient to AOM for home infusion therapy, please contact us at 1-800-746-9089.